TORL-1-23 Clinical Trials

2 actively recruiting trials across 2 locations

Filter by location:

Phoenix, Arizona1 trial

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Mayo Clinic Hospital

Phase 2

Fullerton, California1 trial

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

Providence Medical Foundation

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.